UK Nefopam Prices Continue To Cause Pain
Pricewatch UK – January 2020
Continuing UK price rises were seen for nefopam in January, according to the latest figures from market researcher WaveData.
You may also be interested in...
December brought price rises for the UK generics market that included imipramine prices as much as doubling and a leap of more than two-thirds in the average price of frovatriptan tablets.
Concession prices granted by the UK Department of Health and Social Care targeted some, but not all, of the fastest-rising generics prices in November. The average cost of some presentations more than trebled, according to the latest figures from WaveData.
Bangladesh’s Beximco will market Mylan’s biosimilars in its domestic market, under a deal that has just been struck between the two companies. The Ogivri trastuzumab biosimilar, co-developed by Mylan and Biocon, will be the first product launched as part of the collaboration.